The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
Governor Eric J. Holcomb says he will lead an international trip to Greece next week at the invitation of the Council of ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...
Indiana Gov. Eric Holcomb has appointed David A. Ricks to the Purdue University Board of Trustees, effective Jan. 1, 2025, to ...
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.
In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And ...
A Washington-based surgery center ranked by a nonprofit among the top in the state for minor gender reassignment surgeries ...
LOUISVILLE, Ky. (WDRB) -- Indiana Gov. Eric Holcomb will lead a U.S. delegation to Greece next week at the invitation of the ...
Gov. Eric Holcomb will lead an international trip to the Hellenic Republic, better known as Greece, next week at the ...